Guidelines for Sketching a Curve
Guidelines for Writing Outcome
Guidelines for Nursing Documentation I
Guidelines for Nursing Documentation II
Legal Guidelines for Documentation
Guidelines and Strategies for Safe Computer Charting
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 10, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
Published on: March 20, 2020
Sharon H Giordano1, Anthony D Elias1, William J Gradishar1
1Presented by Sharon H. Giordano, MD, MPH, The University of Texas MD Anderson Cancer Center, Houston, Texas; Anthony D. Elias, MD, University of Colorado Cancer Center, Aurora, Colorado; and William J. Gradishar, MD, Feinberg School of Medicine at Northwestern University, Chicago, Illinois.
Cyclin-dependent kinase 4/6 (CDK4/6) inhibitors have significantly improved progression-free survival in advanced estrogen receptor-positive breast cancer. Personalized treatment strategies are crucial for endocrine therapy duration and other breast cancer subtypes.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: